Volume 4 Supplement 1

3rd Pediatric Allergy and Asthma Meeting (PAAM)

Open Access

P51 - ADRB2 gene polymorphisms of the asthma pediatric patients in Russia’s Perm region

  • Evgenii Furman1,
  • Mariya Ponomareva1,
  • Yurii Pechenkin1 and
  • Irina Koryukina1
Clinical and Translational Allergy20144(Suppl 1):P106

https://doi.org/10.1186/2045-7022-4-S1-P106

Published: 28 February 2014

B2 adrenergic receptor (ADRB2) gene variation could explain differences in bronchodilator response among patients with asthma or identify a subgroup of patients with reduced response.

The aim of our research was identified polymorphisms in the ADRB2 gene in Russian asthma pediatric patients (in Perm region).

44 children from 3 to 18 years of age with bronchial asthma were examined. Mild asthma was in 95,5% , moderate asthma – in 4,5%. Gly16Arg and Gln27Glu mutations of ADRB2 gene were identified by PCR technique.

Results

Gly16Arg mutations of ADRB2 gene was identified in 45,5% and Gln27Glu mutations – in 27,2% (table 1).
Table 1

The distribution of genotypes of ADRB2 gene in children with asthma

Variant

Genotipe

rs1042713

AA

AG

GG

 

%

n

%

n

%

n

 

18,1

8

36,4

16

45,5

20

rs 1042714

CC

CG

GG

 

36,4

16

36,4

16

27,2

12

There were not correlations between severity of bronchial asthma and ADRB2 gene polymorphisms (Gly16Arg and Gln27Glu mutations). The total IgE level was increased in group with Gly16Arg mutation 565,6±242,6 ME/ml, comparatively group without mutation (255±60,31 ME/ml, p=0,563). We found that asthma exacerbations in children with gene mutations occurs after allergen’s exposure in 64% cases. In group without the mutation asthma exacerbations occurs in acute viral respiratory infections in 68% cases.

Thus ADRB2 gene polymorphisms may be associated with clinical features of asthma in children.

Declarations

Acknowledgement

The investigation is supported by the Russian President grant MD № 4241.2012.7

Authors’ Affiliations

(1)
Perm State Medical Academy

Copyright

© Furman et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement